Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

AOD 9604

AOD-9604, Anti-Obesity Drug 9604, Tyr-hGH177-191

Quick Stats
Studies 15
Trials 0
Score 1
2015 pubmed 37 citations

Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry.

Thomas. Andreas A; Görgens. Christian C; Guddat. Sven S; Thieme. Detlef D; Dellanna. Frank F; Schänzer. Wilhelm W; Thevis. Mario M

Key Findings

  • Limits of detection for the peptides are between 50 and 500 pg/mL, well below the 2 ng/mL threshold required for anti‑doping labs.
  • The assay is precise (imprecision <20%) and linear from 0 to 10 ng/mL.
  • Peptides remain stable in urine when stored at –20 °C, and the method successfully identified GHRP‑6, GHRP‑2, and LHRH in real urine samples.

Practical Outcomes

  • For self‑experimenters, the main takeaway is that urine testing can reliably detect AOD‑9604 and similar peptides at very low levels, meaning use could be caught in doping screens. The study does not provide dosing, safety, or efficacy information, so it offers limited direct guidance for how to use the peptide.

Summary

The paper describes a new lab test that can spot tiny amounts of many performance‑enhancing peptides, including AOD‑9604, in urine. It shows the test is very sensitive, works over a useful range, and that the peptides stay stable when urine is kept at –20 °C.

Abstract

The analysis of low-molecular-mass peptides in doping controls has become a mandatory aspect in sports drug testing and, thus, the number of samples that has to be tested for these analytes has been steadily increasing. Several peptides &lt;2 kDa with performance-enhancing properties are covered by the list of prohibited substances of the World Anti-Doping Agency including Desmopressin, LH-RH, Buserelin, Triptorelin, Leuprolide, GHRP-1, GHRP-2, GHRP-3, GHRP-4, GHRP-5,GHRP-6, Alexamorelin, Ipamorelin, Hexarelin, ARA-290, AOD-9604, TB-500 and Anamorelin. With the presented method employing direct urine injection into a liquid chromatograph followed by ion-mobility time-of-flight mass spectrometry, a facile, specific and sensitive assay for the aforementioned peptidic compounds is provided. The accomplished sensitivity allows for limits of detection between 50 and 500&#xa0;pg/mL and thus covers the minimum required performance level of 2 ng/mL accordingly. The method is precise (imprecision &lt;20%) and linear in the estimated working range between 0 and 10 ng/mL. The stability of the peptides in urine was tested, and -20&#xb0;C was found to be the appropriate storage temperature for sports drug testing. Finally, proof-of-concept was shown by analysing elimination study urine samples collected from individuals having administered GHRP-6, GHRP-2, or LHRH.

Study Information

Provider

pubmed

Year

2015

Date

2015-12-15T00:00:00.000Z

DOI

10.1002/jssc.201501060

Citations

37

References

31